Chembio Diagnostic Systems has developed the first dual HIV 1/2 and Syphilis Point-of-Care (POC) test utilizing Chembio’s patented Dual Path Platform (DPP®) technology. The Chembio DPP® HIV-Syphilis Assay is a single-use, immunochromatographic, rapid test for the detection of antibodies to Human Immunodeficiency Virus Types 1 and 2 (HIV 1/2) and Treponema pallidum (the causative agent of syphilis) in fingerstick whole blood, venous whole blood, serum, and plasma.
The Chembio DPP® HIV-Syphilis Assay is intended for use as a point-of-care test to aid in the diagnosis of infection with HIV and/or Syphilis. This test is suitable for use in multi-test algorithms designed for the statistical validation of rapid HIV test results.
A unique feature of this kit is Chembio’s new DPP® SampleTainer® bottle which contains a premeasured dilution buffer within a closed vial that also serves as a dropper for performing the assay. Smart, easy and efficient!
For Use With:
Venipuncture whole blood
Fingerstick whole blood
Accurate results with documented sensitivity and specificity for both HIV 1/2 and Treponema pallidum antibodies on one device
Actionable rapid 15-minute results—allows result and
counseling at point-of-care
Sharp & distinctive visual results
Simple, flexible & safe
Minimal patient sample required, 10 µL finger stick whole blood, serum, or plasma